Yaqian Shi
139 Ren Min Road
Changsha, 410011, China
Changsha, 410011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
A novel LncRNA TUG1/miR-30d/e-3p/SNAI2 ceRNA axis drives dermal fibrosis in systemic sclerosis via direct transcriptional activation of COL1A1.
Journal: International immunopharmacology
Published: May 12, 2026
Cystathionine γ-Lyase-Dependent S-Sulfhydration of Smad3: A Novel Target to Alleviate Fibrosis in Systemic Sclerosis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 20, 2025
Cystathionine γ-lyase-dependent S-sulfhydration of Smad3: A novel target to alleviate fibrosis in systemic sclerosis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 20, 2025
Influential Factors in the Efficacy and Safety of Hemoporfin-Mediated Photodynamic Therapy for Facial Port-Wine Stains.
Journal: Journal of cosmetic dermatology
Published: November 21, 2024
The Role of Non-Coding RNA in Systemic Sclerosis: From Mechanism to Translation.
Journal: Wiley interdisciplinary reviews. RNA
Published: February 08, 2024
Silica's silent threat: Contributing to skin fibrosis in systemic sclerosis by targeting the HDAC4/Smad2/3 pathway.
Journal: Environmental pollution (Barking, Essex : 1987)
Published: January 23, 2024
Further insight into systemic sclerosis from the vasculopathy perspective.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 26, 2023
Pyroptosis: the potential eye of the storm in adult-onset Still's disease.
Journal: Inflammopharmacology
Published: April 15, 2023
ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2/AP-1 in systemic sclerosis.
Journal: International immunopharmacology
Published: March 05, 2023
Overexpressed perforin contributes to the melanocyte destruction via epigenetic regulation in patients with vitiligo.
Journal: International immunopharmacology
Published: November 04, 2022
Last Updated: 09/26/2026